Tag: Paragraph IV certification
Why the First Generic Filer Gets 180-Day Exclusivity in the U.S. Drug Market
The first generic drug company to file a patent challenge gets 180 days of exclusive sales rights. But this rule, meant to lower drug prices, is often manipulated-delaying competition and keeping patients from affordable medicines.
read morerecent posts
Hospitals choose generic drugs based on clinical safety, supply reliability, and real-world performance-not just price. Learn how Pharmacy and Therapeutics committees make these critical decisions under growing economic and regulatory pressure.
Published ON: 7 FebCardiac rehabilitation after a heart attack or surgery is a proven, supervised program that helps you recover safely, reduce future heart risks, and get back to daily life. Learn how it works, who qualifies, and why so few people take advantage of it.
Published ON: 11 FebGeneric and brand-name drugs have the same active ingredients, so their risk for drug interactions is essentially identical. Learn what really matters - and what doesn't - when switching medications.
Published ON: 2 FebLearn how tablet, capsule, and extended-release formulations affect drug absorption and side effects. Discover why ER pills reduce nausea and dizziness - and when they might not be the best choice.
Published ON: 3 FebGeneric drugs save money, but counterfeit versions put lives at risk. Learn how strict quality control standards like cGMP, serialization, and advanced testing prevent fake medicines from reaching patients - and why they work better than you think.
Published ON: 12 Feb